Hong Kong Drug Licence Applications and Acquisitions · RGYS|Global Licensing and Compliance Service Provider
Hong Kong pharmaceutical compliance · applications / acquisitions / ongoing maintenance Independent Third-Party Service Provider
HONG KONG DRUG LICENSING

How high is the financial threshold for applying for a pharmaceutical product manufacturing licence (Manufacturer Licence)? Where is the main investment required?

A complete explanation of the regulatory basis, Drew Tang’s recommendations and risk alerts. The original material dates from 2025; read it alongside the latest official requirements.

Original guide, 2025 edition: These FAQs are provided for topic-based reference and have not all been individually checked against current rules. Please confirm fees, personnel, renewal, changes and product requirements against the professional in-depth guide for the relevant licence type and the official requirements in force at the time.

Drug Office, Department of Health Chinese Medicines Board

Q258 · Category F: Fees, Budget and Financial Planning (Q251-Q300)
Applying for a pharmaceutical product manufacturer's licence (Pharmaceutical Manufacturer License) has the highest financial threshold of all licence types, and the investment is typically measured in tens of millions of Hong Kong dollars. The main investment areas are as follows. First, “factory construction and certification”: you need to establish a facility meeting Good Manufacturing Practice (GMP) standards, including specially designed cleanrooms, separate stores for materials and finished products, and advanced ventilation and water treatment systems. Second, “production and testing equipment”: substantial investment is required to purchase GMP-compliant production line equipment and precision analytical instruments for the quality control laboratory. Finally, “specialist technical staff”: highly skilled personnel, including a production supervisor and quality control/quality assurance managers, must be employed.

📘 Regulatory basis

The Pharmacy and Poisons Board (PPB) requires all licensed pharmaceutical product manufacturers to comply with the PIC/S Guide to Good Manufacturing Practice for Medicinal Products. This is the core technical and legal standard for applying for and maintaining a licence.

📗 Drew Tang's recommendations

For investors interested in entering pharmaceutical manufacturing, Rengangyongsheng (Hong Kong) Limited generally recommends conducting a highly detailed feasibility study and financial planning. Consider starting with contract manufacturing (CMO), using the capacity of an existing licensed manufacturer, and only considering a facility of your own once the market and products have matured. This can substantially reduce initial investment risk.

📕 Risk notice

Constructing and certifying a GMP facility takes a long time, requires substantial investment and involves considerable uncertainty. Failure at any stage of the stringent PIC/S review may cause the entire project to fail, resulting in substantial financial losses. This is a highly specialised, capital- and technology-intensive field and should not be entered into lightly.

Back to Category F: Fees, Budget and Financial Planning (Q251-Q300) Search more questions

YOUR NEXT STEP

Plan Your Hong Kong Pharmaceutical Licensing Project with Drew Tang

Business Manager Tang Shangyong (Drew Tang) will review your products, operating model, licence type and preparation requirements with you one-to-one. The precise service scope is confirmed in writing; pharmaceutical duties are carried out by legally qualified personnel, and approvals are determined by the competent authorities.

Book a Project Assessment ↗